Cancer Treatment Biz Crism Raises £2.5M With Placing
Crism Therapeutics Corp. said Tuesday it has raised £2.5 million ($3.4 million) through a share issue, which the clinical-stage company that focuses on the delivery of chemotherapy drugs plans to use for...To view the full article, register now.
Already a subscriber? Click here to view full article